×
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
LON:BPCR

BioPharma Credit Share Forecast, Price & News

GBX 0.93
+0.00 (+0.32%)
(As of 06/27/2022 12:37 PM ET)
Add
Compare
Today's Range
0.92
0.93
50-Day Range
0.93
1.02
52-Week Range
0.92
1.05
Volume
3.21 million shs
Average Volume
1.97 million shs
Market Capitalization
£12.79 million
P/E Ratio
15.02
Dividend Yield
7.54%
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive BPCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter.

BPCR Stock Forecast (MarketRank)

Overall MarketRank

1.56 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.

BPCR Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
Sector
Finance
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Company Calendar

Ex-Dividend for 3/31 Dividend
3/03/2022
Dividend Payable
3/31/2022
Ex-Dividend for 5/31 Dividend
5/05/2022
Dividend Payable
5/31/2022
Today
6/27/2022
Next Earnings (Estimated)
9/13/2022

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£103.88 million
Cash Flow
GBX 6.75 per share
Book Value
GBX 99.30 per share

Miscellaneous

Outstanding Shares
1,373,872,000
Free Float
N/A
Market Cap
£12.79 million
Optionable
Not Optionable
Beta
N/A














BioPharma Credit Frequently Asked Questions

How has BioPharma Credit's stock performed in 2022?

BioPharma Credit's stock was trading at GBX 0.97 at the beginning of 2022. Since then, BPCR stock has decreased by 3.8% and is now trading at GBX 0.93.
View the best growth stocks for 2022 here
.

When is BioPharma Credit's next earnings date?

BioPharma Credit is scheduled to release its next quarterly earnings announcement on Tuesday, September 13th 2022.
View our earnings forecast for BioPharma Credit
.

How often does BioPharma Credit pay dividends? What is the dividend yield for BioPharma Credit?

BioPharma Credit announced a dividend on Wednesday, April 27th. Shareholders of record on Thursday, May 5th will be paid a dividend of GBX 0.02 per share on Tuesday, May 31st. This represents a yield of 1.76%. The ex-dividend date is Thursday, May 5th. The official announcement can be viewed at this link.
View BioPharma Credit's dividend history
.

Is BioPharma Credit a good dividend stock?

BioPharma Credit(LON:BPCR) pays an annual dividend of GBX 0.07 per share and currently has a dividend yield of 7.54%. BPCR has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of BioPharma Credit is 112.90%. Payout ratios above 75% are not desirable because they may not be sustainable.
View BioPharma Credit's dividend history.

Who are BioPharma Credit's key executives?

BioPharma Credit's management team includes the following people:
  • Mr. Pedro Gonzalez de Cosio, Investment Mang.
  • Mr. Pablo Gerardo Legorreta, Investment Mang. (Age 57)
  • Mr. Martin G. Friedman, Investment Mang. (Age 57)

What other stocks do shareholders of BioPharma Credit own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioPharma Credit investors own include AFPO.L (AFPO), Altius Minerals (ATUSF), LiDCO Group Plc (LID.L) (LID), 21512 (SAT.L) (SAT), San Juan Basin Royalty Trust (SJT), ANGLE (AGL), Hochschild Mining (HOC), SPX FLOW (FLOW), Fulcrum Utility Services (FCRM) and DX (Group) (DX).

What is BioPharma Credit's stock symbol?

BioPharma Credit trades on the London Stock Exchange (LON) under the ticker symbol "BPCR."

How do I buy shares of BioPharma Credit?

Shares of BPCR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is BioPharma Credit's stock price today?

One share of BPCR stock can currently be purchased for approximately GBX 0.93.

How much money does BioPharma Credit make?

BioPharma Credit (LON:BPCR) has a market capitalization of £12.79 million and generates £103.88 million in revenue each year.

How can I contact BioPharma Credit?

BioPharma Credit's mailing address is Beaufort HSE, 51 New North Road, EXETER, EX4 4EP, United Kingdom. The official website for BioPharma Credit is www.bpcruk.com. The company can be reached via phone at 44 13 9247 7500.

This page (LON:BPCR) was last updated on 6/27/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.